Concepedia

David E. Heppner

DE

30

Publications

2.2K

Citations

23

H-Index

2005

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

University of Vermont

University at Buffalo, State University of New York

University of Tübingen

David E. Heppner is an author at Harvard University specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2005–2024

30

Publications

30

A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging

Haopeng Xiao, Mark P. Jedrychowski, Devin K. Schweppe et al. · Cell · 2020 · 388 citations · Full text

, , +10

Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor

Ciric To, Jaebong Jang, Ting Chen et al. · Cancer Discovery · 2019 · 319 citations · Full text

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 146 citations · Full text

, , +9

Direct cysteine sulfenylation drives activation of the Src kinase

David E. Heppner, Christopher M. Dustin, Chenyi Liao et al. · Nature Communications · 2018 · 137 citations · Full text

Reaction Coordinate of a Functional Model of Tyrosinase: Spectroscopic and Computational Characterization

Bryan T. Op’t Holt, M.A. Vance, Liviu M. Mirica et al. · Journal of the American Chemical Society · 2009 · 108 citations · Full text

Rows per page

1–5 of 30